Completed Experimental Vaccine for Prevention of Ebola Virus Infection NCT00374309 Conditions Ebola Hemorrhagic Fever, Ebola Virus Disease, Ebola Virus Vaccines, +9 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
